Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03726437 · ClinicalTrials.gov registry record · NA
Efficacy of a Web-based Sexual Violence Risk Reduction Program for Female College Students
A NA study, sponsored by Georgia State University.
- Completed
- Registry status
- NA
- Development phase
- 881
- Enrollment target
NCT03726437: Completed NA study, sponsored by Georgia State University.
NCT03726437 is a NA study that has completed, run by Georgia State University. The registered enrollment target is 881 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (37% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03726437, a NA study, has completed, sponsored by Georgia State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 881 participants
- Enrollment target
Study Summary
This study evaluates the efficacy of a web-based program for female college freshmen ("RealConsent") in reducing their risk of sexual violence victimization. Half the participants will receive RealConsent-F and half will receive an attention-placebo control ("Stress and Mood Management").
Primary Outcome
Sexual assault victimization was assessed with Revised Sexual Experience Survey. Participants were asked how often they experienced 7 unwanted sexual experiences. Also, the tactic that was used ("using force") was also noted. Response options ranged from 0 (never) to 3 (3+times). An overall score for the SES, was calculated by summing each outcome and tactic score ("SOTS") with a range from 0 to 135- with higher scores indicating more sexual violence victimization. The 2nd method combines severa
Interventions
- BEHAVIORAL RealConsent
- BEHAVIORAL Stress and Mood Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 881 participants |
| Start Date | 2018-10-17 |
| Est. Completion | 2019-11-01 |
| Phase | NA |
What the finished NCT03726437 record still lists
NCT03726437 is an interventional study that assigns participants to a tested intervention. The registered 881 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (37% lower).
The record links to 0 conditions, and to 2 interventions - of which RealConsent is the first listed.
NCT03726437 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03726437 about?
NCT03726437 is a clinical study titled "Efficacy of a Web-based Sexual Violence Risk Reduction Program for Female College Students". This study evaluates the efficacy of a web-based program for female college freshmen ("RealConsent") in reducing their risk of sexual violence victimization. Half the participants will receive RealConsent-F and half will receive an attention-placebo control ("Stress and Mood Management").
What is the current status of trial NCT03726437?
This trial is currently completed. It is a NA study. The enrollment target is 881 participants. The study started on 2018-10-17. Estimated completion is 2019-11-01.
What interventions are being tested in trial NCT03726437?
The interventions under investigation include: RealConsent (BEHAVIORAL), Stress and Mood Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT03726437?
This trial is sponsored by Georgia State University, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03726437's enrollment target sits among peer trials
881 130th of 2000 higher than 1,871 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07196748 · 882 participants · Phase 3
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- NCT05174286 · 880 participants · NA
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
- NCT05454280 · 880 participants · Phase 3
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
- NCT05525663 · 880 participants · NA
Physical Rehabilitation for Older Patients With Acute Heart Failure With Preserved Ejection Fraction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI